Brief: Cyclo Therapeutics And Applied Molecular Transport Enter Into A Definitive Merger Agreement

Applied Molecular Transport.

21/09/2023 13:26

Sept 21 (Reuters) - Applied Molecular Transport Inc.
 AMTI.O :
    * CYCLO THERAPEUTICS, INC. AND APPLIED MOLECULAR TRANSPORT
INC.
ENTER INTO A DEFINITIVE MERGER AGREEMENT
    * APPLIED MOLECULAR TRANSPORT: STOCKHOLDERS WILL RECEIVE
APPROXIMATELY 0.174 SHARES OF CYCLO THERAPEUTICS IN EXCHANGE FOR
EACH OF THEIR SHARES IN AMT
    * APPLIED MOLECULAR TRANSPORT INC. - TRANSACTION IS
CURRENTLY
EXPECTED TO CLOSE IN Q4 OF 2023
    * APPLIED MOLECULAR TRANSPORT INC.: COMBINED COMPANY WILL
OPERATE
AS CYCLO THERAPEUTICS
    * APPLIED MOLECULAR TRANSPORT INC. - COMBINED CO WILL BE LED
BY
EXISTING CYCLO THERAPEUTICS MANAGEMENT TEAM AND WILL BE
HEADQUARTERED IN GAINESVILLE
    * APPLIED MOLECULAR TRANSPORT- UPON DEAL SHAWN CROSS, CEO
AND
BOARD CHAIR OF AMT WILL BE APPOINTED TO CYCLO THERAPEUTICS BOARD
OF DIRECTORS
    * APPLIED MOLECULAR: CYCLO THERAPEUTICS EXPECTS TO ISSUE
APPROXIMATELY 7.624 MILLION SHARES OF CYCLO THERAPEUTICS' COMMON
STOCK TO AMT SHAREHOLDERS

Source text for Eikon:  ID:nBw79jzPba 
Further company coverage:  AMTI.O 

 ((Reuters.Briefs@thomsonreuters.com))